Senior insider sale
President and CEO at ARS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.51M
255.65K shares
What this filing means
LOWENTHAL RICHARD E plans to sell 255.65K shares of ARS PHARMACEUTICALS, INC. valued at approximately $1.51M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/11/2026ACC: 0001950047-26-009340
DirectorOfficer10% Owner· President and CEO
Since Nov 2022
255.65K
Shares to sell
$1.51M
Approx. market value
35K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
9/11/2026
35KTotal acquired35K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/11/2026 | Stock Option Exercise Cash | 35K | — |
| Total | 35K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
75K
Market value
$421.1K
9/4/2026
—Completed
Units to sell
19.80K
Market value
$115.6K
9/3/2026
—Completed
Units to sell
840.00
Market value
$5.0K
9/2/2026
—Completed
Units to sell
25K
Market value
$148.2K
8/20/2026
—Completed
Units to sell
50K
Market value
$322.3K
8/19/2026
—Completed
Units to sell
50K
Market value
$315.9K
8/18/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
35K
Market value
$177.0K
9/11/2026
Total
Units
255.65K
Value
$1.51M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/4/2026 | 75K | $421.1K | — | Completed |
9/3/2026 | 19.80K | $115.6K | — | Completed |
9/2/2026 | 840.00 | $5.0K | — | Completed |
8/20/2026 | 25K | $148.2K | — | Completed |
8/19/2026 | 50K | $322.3K | — | Completed |
8/18/2026 | 50K | $315.9K | — | Completed |
| Planned — Approximate Date | ||||
9/11/2026 | 35K | $177.0K | NASDAQ | Planned |
| Total | 255.65K | $1.51M | ||